Israel's BrainStorm says stem cell drug benefits ALS patients
April 21, 2015 at 06:30 AM EDT
TEL AVIV, April 21 (Reuters) - Israel's BrainStorm Cell Therapeutics said a mid-stage clinical trial of its adult stem cell treatment showed a "statistically significant" effect in patients with amyotrophic lateral sclerosis (ALS).
